| Curcumin delivery mediated by bio-based nanoparticles: a review M Moballegh Nasery, B Abadi, D Poormoghadam, A Zarrabi, P Keyhanvar, ... Molecules 25 (3), 689, 2020 | 214 | 2020 |
| Naringenin nano-delivery systems and their therapeutic applications M Bhia, M Motallebi, B Abadi, A Zarepour, M Pereira-Silva, F Saremnejad, ... Pharmaceutics 13 (2), 291, 2021 | 107 | 2021 |
| Electrospun hybrid nanofibers: Fabrication, characterization, and biomedical applications B Abadi, N Goshtasbi, S Bolourian, J Tahsili, M Adeli-Sardou, ... Frontiers in Bioengineering and Biotechnology 10, 986975, 2022 | 38 | 2022 |
| Smart biomaterials to enhance the efficiency of immunotherapy in glioblastoma: State of the art and future perspectives B Abadi, N Yazdanpanah, A Nokhodchi, N Rezaei Advanced Drug Delivery Reviews 179, 114035, 2021 | 29 | 2021 |
| Capping agents for selenium nanoparticles in biomedical applications B Abadi, S Hosseinalipour, S Nikzad, S Pourshaikhali, ... Journal of Cluster Science 34 (4), 1669-1690, 2023 | 15 | 2023 |
| Current status and challenges of stem cell-based therapy for the treating of glioblastoma multiforme B Abadi, M Ahmadi-Zeidabadi, L Dini, C Vergallo Hematology/Oncology and Stem Cell Therapy 14 (1), 1-15, 2021 | 14 | 2021 |
| Antidepressants with anti‐tumor potential in treating glioblastoma: A narrative review B Abadi, Y Shahsavani, M Faramarzpour, N Rezaei, HR Rahimi Fundamental & Clinical Pharmacology 36 (1), 35-48, 2022 | 13 | 2022 |
| Cellular conversations in glioblastoma progression, diagnosis and treatment AK Sisakht, M Malekan, F Ghobadinezhad, SNM Firouzabadi, A Jafari, ... Cellular and molecular neurobiology 43 (2), 585-603, 2023 | 12 | 2023 |
| Chitosan-sialic acid nanoparticles of selenium: Statistical optimization of production, characterization, and assessment of cytotoxic effects against two human glioblastoma … B Abadi, P Khazaeli, H Forootanfar, M Ranjbar, M Ahmadi-Zeidabadi, ... International Journal of Pharmaceutics 637, 122884, 2023 | 7 | 2023 |
| The effect of low-and moderate-intensity interval training on cognitive behaviors of male and female rats with VPA-induced autism N Sabet, B Abadi, A Moslemizadeh, MA Rajizadeh, F Arabzadehe, ... Heliyon, 2023 | 4 | 2023 |
| Antibiotics with antiviral and anti-inflammatory potential against COVID-19: A review B Abadi, M Ilaghi, Y Shahsavani, M Faramarzpour, MB Oghazian, ... Current Reviews in Clinical and Experimental Pharmacology Formerly Current …, 2023 | 3 | 2023 |
| Biomimetic Nanotechnology for Cancer Immunotherapy: State of the Art and Future Perspective AS Lotfabadi, B Abadi, N Rezaei International Journal of Pharmaceutics, 123923, 2024 | 2 | 2024 |
| Therapeutic strategies in the fight against COVID-19: from bench to bedside B Abadi, AHA Jeshvaghani, H Fathalipour, L Dehghan, KR Sirjani, ... Iranian Journal of Medical Sciences 47 (6), 517, 2022 | 2 | 2022 |
| Fluorescent carbon dots from cumin seeds: preparation, characterization and in vitro biocompatibility test for cell imaging application B Abadi, F Askarian, N Mohamadi, B Behnam Journal of Cluster Science 35 (5), 1521-1531, 2024 | | 2024 |
| Silibinin improved the function of T cells in peripheral blood mononuclear cells (PBMCs) co-cultured with U-87 MG cell line. B Abadi, J Abdesheikhi, F Sedghy, M Mahmoodi, H Fallah Avicenna Journal of Phytomedicine 14 (2), 2024 | | 2024 |
| Introduction on Personalized Immune-Oncology B Abadi, N Rezaei Handbook of Cancer and Immunology, 1-25, 2022 | | 2022 |
| Smart bio-encapsulation for immunotherapy M Moballegh Nasery, B Abadi, N Seyedpour, P Bazdar, T Eslaminejad Smart Nanomaterials for Bioencapsulation, 75-90, 2022 | | 2022 |
| Astrocytic Abnormalities in Schizophrenia K Saleki, M Banazadeh, B Abadi, Z Pirmoradi, Z Esmaili, S Amiri, ... Neurophysiology-Networks, Plasticity, Pathophysiology and Behavior, 2022 | | 2022 |
Mahshid Moballegh NaseryDepartment of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen在 med.unideb.hu 的电子邮件经过验证
